Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Early research (Phase 1)Active Not RecruitingNCT07038369What this trial is testingATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsWho this might be right forAdvanced Solid TumorsBreast CancerBreast Carcinoma+24 more Atavistik Bio, Inc 134
Early research (Phase 1)Study completedNCT03207529What this trial is testingAlpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more M.D. Anderson Cancer Center 18
Early research (Phase 1)Active Not RecruitingNCT03589339What this trial is testingNBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyWho this might be right forRadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more Nanobiotix 145
Not applicableEnded earlyNCT01836640What this trial is testingDeveloping Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer Dartmouth-Hitchcock Medical Center 9
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)UnknownNCT02506777What this trial is testingNeoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.Who this might be right forBreast Cancer N.N. Petrov National Medical Research Center of Oncology 96
Early research (Phase 1)Looking for participantsNCT06493864What this trial is testingBL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid TumorsWho this might be right forBreast CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)UnknownNCT04963595What this trial is testingPyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Zhiyong Yu 100
Large-scale testing (Phase 3)Looking for participantsNCT06757634What this trial is testingPhase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Who this might be right forBreast Cancer Celcuity Inc 1,180
Testing effectiveness (Phase 2)Study completedNCT00951665What this trial is testingTrastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Genentech, Inc. 107
Testing effectiveness (Phase 2)Study completedNCT00106002What this trial is testingPemetrexed as the First Treatment in Advanced or Metastatic Breast CancerWho this might be right forBreast CancerBreast Neoplasms, MaleCarcinoma, Ductal Eli Lilly and Company 37
Early research (Phase 1)Ended earlyNCT02512237What this trial is testingA Dose-escalation Study of ARX788, IV Administered in Subjects With Advanced Cancers With HER2 ExpressionWho this might be right forBreast NeoplasmsStomach Neoplasms Zhejiang Medicine Co., Ltd. 9
Not applicableStudy completedNCT06307457What this trial is testingHR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.Who this might be right forBreast Cancer Pfizer 604
Testing effectiveness (Phase 2)Ended earlyNCT01832857What this trial is testingPhase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer PatientsWho this might be right forCancer Cornerstone Pharmaceuticals 7
Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT02007512What this trial is testingEfficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerWho this might be right forBreast Cancer Pfizer 247
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439175What this trial is testingTesting GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Looking for participantsNCT04090567What this trial is testingOlaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerWho this might be right forAdvanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+12 more M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT03800836What this trial is testingEvaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 139